Bank Julius Baer & Co. Ltd Zurich Sells 14,627 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bank Julius Baer & Co. Ltd Zurich reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 613,290 shares of the exchange traded fund’s stock after selling 14,627 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in SPDR S&P Biotech ETF were worth $54,761,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. James J. Burns & Company LLC grew its holdings in shares of SPDR S&P Biotech ETF by 5.0% during the 3rd quarter. James J. Burns & Company LLC now owns 3,062 shares of the exchange traded fund’s stock valued at $224,000 after purchasing an additional 146 shares during the last quarter. Greenwich Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 1.4% during the 4th quarter. Greenwich Wealth Management LLC now owns 11,451 shares of the exchange traded fund’s stock worth $1,022,000 after buying an additional 155 shares during the period. Moser Wealth Advisors LLC boosted its position in SPDR S&P Biotech ETF by 10.4% during the 3rd quarter. Moser Wealth Advisors LLC now owns 2,041 shares of the exchange traded fund’s stock worth $149,000 after buying an additional 193 shares during the period. Viewpoint Capital Management LLC boosted its position in SPDR S&P Biotech ETF by 25.0% during the 3rd quarter. Viewpoint Capital Management LLC now owns 1,000 shares of the exchange traded fund’s stock worth $73,000 after buying an additional 200 shares during the period. Finally, HB Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 4.9% during the 4th quarter. HB Wealth Management LLC now owns 4,280 shares of the exchange traded fund’s stock worth $382,000 after buying an additional 200 shares during the period.

SPDR S&P Biotech ETF Trading Down 2.0 %

NYSEARCA:XBI traded down $1.72 during mid-day trading on Thursday, hitting $82.22. 14,305,248 shares of the company’s stock were exchanged, compared to its average volume of 11,739,715. The company has a 50 day simple moving average of $92.88 and a 200-day simple moving average of $84.55. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The firm has a market capitalization of $6.39 billion, a P/E ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.